Abstract
Giant cell arteritis (GCA), or temporal arteritis, is a medium to large vessel vasculitis seen in the elderly. Its presentation varies from fever of unknown origin to cranial ischemic complications including complete vision loss. The early initiation of steroids is key to preventing complications of GCA. Here we discuss the role of aspirin in the treatment of GCA, both as an antithrombotic agent and its increasingly utilized antiinflammatory properties. The aim of this review article is to examine the evidence behind the rationale of aspirin use as an adjunct to steroids for the prevention of cranial ischemic complications.
Recommended Citation
Qureshi, Anum; Halilu, Fatima; Serafi, Sam W.; Hauptman, Howard; and Flack, Tristan
(2022)
"Evidence-based Role of Aspirin in Giant Cell Arteritis: A Literature Review,"
Journal of Community Hospital Internal Medicine Perspectives: Vol. 12:
Iss.
5, Article 3.
DOI: 10.55729/2000-9666.1072
Available at:
https://scholarlycommons.gbmc.org/jchimp/vol12/iss5/3
